Open AccessAnalysis of risk factors of stage IV gastric cancer from the SEER database
Author(s) -
Ge Xy,
Ge F,
Z Wang,
Yuliang Wang,
Lei Lw,
Liu Qr,
Xi Sun,
Xian Jiang
Publication year - 2020
Publication title -
annals of the royal college of surgeons of england
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.39
H-Index - 63
eISSN - 1478-7083
pISSN - 0035-8843
DOI - 10.1308/rcsann.2020.0031
Subject(s) - medicine , gastrectomy , cancer , stage (stratigraphy) , dissection (medical) , lymph node , surgery , metastasis , chemotherapy , epidemiology , oncology , paleontology , biology
Gastric cancer is the fourth most common cancer in the world. By the time the patients are diagnosed with stage IV gastric cancer, many patients already have distant metastases. There is no unified systemic treatment plan in existence. The use of gastrectomy is ambiguous in patients with stage IV gastric cancer. The objective of this study was to evaluate the beneficial outcome of gastrectomy in patients with stage IV gastric cancer.